Proteomics International Laboratories Ltd (ASX:PIQ)

Australia flag Australia · Delayed Price · Currency is AUD
0.325
+0.005 (1.54%)
Mar 9, 2026, 10:00 AM AEST
-36.27%
Market Cap 53.68M
Revenue (ttm) 3.21M
Net Income (ttm) -9.66M
Shares Out 165.18M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,887
Average Volume 403,597
Open 0.330
Previous Close 0.325
Day's Range 0.325 - 0.330
52-Week Range 0.285 - 0.860
Beta -0.51
RSI 29.92
Earnings Date Feb 23, 2026

About ASX:PIQ

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has comple... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PIQ
Full Company Profile

Financial Performance

In fiscal year 2025, ASX:PIQ's revenue was 3.31 million, an increase of 1.34% compared to the previous year's 3.27 million. Losses were -8.11 million, 27.3% more than in 2024.

Financial Statements

News

There is no news available yet.